By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
NCI Japan Purchases ViewRay MRIdian System 9/21/2016 8:20:47 AM
Abilita Bio Awarded NCI Phase-I SBIR Grant To Develop Therapeutic Antibodies Targeting Metastatic Breast Cancer 9/20/2016 10:38:22 AM
BioMarker Strategies Awarded Phase I NCI Contract To Develop Novel Predictive Test For Response To Immunotherapies For Patients With Non-Small Cell Lung Cancer 9/19/2016 11:11:25 AM
Lumicell Awarded Direct Phase II SBIR Grant From The NCI To Conduct Multi-Center Pivotal Study 8/9/2016 12:44:00 PM
Cellectar Biosciences  (CLRB) Announces $2 Million NCI SBIR Contract For A Phase II Clinical Study 8/3/2016 8:43:35 AM
Advanced Accelerator Applications Announces Clinical Trial Agreement With NCI For Study Of Lutathera In Patients With Inoperable Pheochromocytoma And Paraganglioma 8/2/2016 8:10:23 AM
President's Cancer Moonshot Initiative Fosters Breakthrough Collaboration Between The Colon Cancer Alliance, Smart Patients, And The Colon Cancer Alliance 6/30/2016 9:21:36 AM
Cellectar Biosciences  (CLRB) Announces Results Of NCI-Sponsored Study Of CLR 125 Showing Potential Effect Against Triple Negative Breast Cancer 6/23/2016 7:53:47 AM
Kite Pharma (KITE) Expands Development Of T-Cell Receptor (TCR) Therapies Targeting HPV-Associated Cancers In Partnership With The NCI 6/20/2016 10:45:28 AM
Pharmaron LLC Joins The NCI’s Chemical Biology Consortium To Fight Against Cancer 6/14/2016 8:18:15 AM
12345678910...
//-->